Timing of Mycobacterium tuberculosis exposure explains variation in BCG effectiveness: a systematic review and meta-analysis
- Author(s)
- Trauer, JM; Kawai, A; Coussens, AK; Datta, M; Williams, BM; McBryde, ES; Ragonnet, R;
- Journal Title
- Thorax
- Publication Type
- epub ahead of print
- Abstract
- RATIONALE: The heterogeneity in efficacy observed in studies of BCG vaccination is not fully explained by currently accepted hypotheses, such as latitudinal gradient in non-tuberculous mycobacteria exposure. METHODS: We updated previous systematic reviews of the effectiveness of BCG vaccination to 31 December 2020. We employed an identical search strategy and inclusion/exclusion criteria to these earlier reviews, but reclassified several studies, developed an alternative classification system and considered study demography, diagnostic approach and tuberculosis (TB)-related epidemiological context. MAIN RESULTS: Of 21 included trials, those recruiting neonates and children aged under 5 were consistent in demonstrating considerable protection against TB for several years. Trials in high-burden settings with shorter follow-up also showed considerable protection, as did most trials in settings of declining burden with longer follow-up. However, the few trials performed in high-burden settings with longer follow-up showed no protection, sometimes with higher case rates in the vaccinated than the controls in the later follow-up period. CONCLUSIONS: The most plausible explanatory hypothesis for these results is that BCG protects against TB that results from exposure shortly after vaccination. However, we found no evidence of protection when exposure occurs later from vaccination, which would be of greater importance in trials in high-burden settings with longer follow-up. In settings of declining burden, most exposure occurs shortly following vaccination and the sustained protection observed for many years thereafter represents continued protection against this early exposure. By contrast, in settings of continued intense transmission, initial protection subsequently declines with repeated exposure to Mycobacterium tuberculosis or other pathogens.
- Publisher
- BMJ Journals
- Keywords
- clinical epidemiology; respiratory infection; tuberculosis
- Research Division(s)
- Infectious Diseases And Immune Defence
- PubMed ID
- 33893231
- Publisher's Version
- https://doi.org/10.1136/thoraxjnl-2020-216794
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2021-05-11 02:09:55
Last Modified: 2021-11-10 10:36:06